Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)

Trial Profile

A 12-Month Open-Label, Repeat-Dose Safety Study of NRL-1 in Epilepsy Subjects (DIAZ.001.05)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diazepam (Primary) ; Benzodiazepines
  • Indications Epilepsy; Generalised epilepsy; Partial epilepsies; Seizures
  • Focus Registrational; Therapeutic Use
  • Sponsors Neurelis
  • Most Recent Events

    • 04 Jan 2024 Results of exploratory Post Hoc analysis assessing effect of timing of rescue therapy administration for seizure clusters in epilepsy , published in the Neurology and Therapy
    • 01 Dec 2023 Results presented in a Neurelis Media Release.
    • 01 Dec 2023 According to a Neurelis Media Release, post-hoc analysis data from this study will present six poster presentations at the American Epilepsy Society (AES) Annual Meeting held in Orlando, Florida from December 1-5, 2023.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top